BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 15, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 5, 2001
View Archived Issues
Clash Over Stem Cell Research Delayed As Bush Mulls Options
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER-MARKET PERFORMANCE* #
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY AFTER-MARKET PERFORMANCE#
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER-MARKET PERFORMANCE#
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY AFTER-MARKET PERFORMANCE#
Read More
